Valuation, from the filing
| Public float | $19.90B | Market value of stock held by non-affiliates, as stated on the cover page for 2024-12-31 |
|---|---|---|
| Float per share | $162.70 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
| Float / net income | 24.6× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / revenue | 2.8× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / equity | 41.3× | A lower bound on the multiple, because affiliate holdings are excluded. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2024-12-31, not today, and each multiple below it uses the figures for the fiscal year ending 2025-06-30 — the year that filing covered.
Valuation over time
24.6× earnings today, against a median of 24.9× across 10 years on record. In line with its own history.
| Float measured | Public float | Float / net income | |
|---|---|---|---|
| 2024-12-31 | $19.90B | 24.6× | |
| 2023-12-29 | $17.70B | 63.2× | |
| 2022-12-30 | $17.30B | 116.1× | |
| 2021-12-31 | $21.40B | 46.3× | |
| 2020-12-31 | $25.30B | 35.6× | |
| 2019-12-31 | $19.00B | 20.2× | |
| 2018-12-31 | $19.70B | 24.0× | |
| 2017-12-29 | $19.20B | 23.3× | |
| 2016-12-30 | $15.40B | 22.0× | |
| 2015-12-31 | $16.40B | 25.3× |
Each float is paired with the fiscal year the filing that stated it covers. Only years where the company reported positive net income appear, because a multiple against a loss is not a multiple.
CLOROX CO /DE/ (CLX) reported revenue of $6.76B and net income of $756.00M for the fiscal year ended 2026-03-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from CLOROX CO /DE/’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2026-03-31 |
|---|---|
| Revenue | $6.76B |
| Cost of revenue | $3.80B |
| Gross profit | $2.96B |
| Operating income | Unavailable |
| Net income | $756.00M |
| Research & development | $116.00M |
| Weighted-average diluted shares | Unavailable |
| Pretax income | $988.00M |
| Income tax expense | $218.00M |
| Diluted EPS | Unavailable |
| Selling, general & administrative | $1.06B |
| General & administrative | Unavailable |
| Selling & marketing | Unavailable |
Balance
| Metric | 2026-03-31 |
|---|---|
| Cash & equivalents | $1.19B |
| Total assets | $6.44B |
| Current assets | $2.65B |
| Total liabilities | $6.34B |
| Current liabilities | $3.16B |
| Total equity incl. NCI | $92.00M |
| Temporary (mezzanine) equity | Unavailable |
| Inventory | $588.00M |
| Accounts receivable | $671.00M |
| Goodwill | $1.23B |
| Long-term debt | $2.49B |
| Accounts payable | Unavailable |
Cash flow
| Metric | 2026-03-31 |
|---|---|
| Operating cash flow | $576.00M |
| Capital expenditures | $196.00M |
| Investing cash flow | -$196.00M |
| Financing cash flow | $578.00M |
| Net change in cash | $958.00M |
| Stock-based compensation | $66.00M |
| Common dividends paid | $602.00M |
| Common share repurchases | $331.00M |
| Depreciation & amortization | $226.00M |
Derived
| Metric | 2026-03-31 |
|---|---|
| Free cash flow | $380.00M |
| Gross margin | 43.8% |
| Operating margin | Unavailable |
| FCF margin | 5.6% |
| SBC / revenue | 1.0% |
| Current ratio | 0.84x |
| Revenue YoY growth | -3.7% |
| Net margin | 11.2% |
| R&D / revenue | 1.7% |
| CapEx / revenue | 2.9% |
| Long-term debt / equity | 27.03x |
| Effective tax rate | 22.1% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CLX in the interactive workspace to inspect any figure back to its filing.
Source filings
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.